Arrowhead boasts a diversified RNAi pipeline targeting liver, lung, muscle, CNS, and obesity. Read why I recommend buying and ...

Eli Lilly posts 54% revenue growth, raises guidance, and drives innovation in obesity and diabetes care. Read here for an ...

Looking for cheap 400-hp muscle? Here are 10 used V8 cars that mix serious power with surprising affordability on the used ...

Q3 2025 Management View CEO Sergio Traversa highlighted a "standout year" for Relmada, citing "excellent product development ...

WVE-007, an INHBE GalNAc-siRNA for obesity designed to drive fat loss while preserving muscle mass, achieved dose-dependent, mean reductions of ...

AEW Full Gear 2025 brought All Elite Wrestling back to the Prudential Center in Newark, New Jersey for a night of major ...

ADVANCED-2 (NCT05951179) is a Phase 2 open-label trial assessing intravesical TARA-002 in NMIBC patients with carcinoma in situ or CIS (± Ta/T1) who are Bacillus Calmette-Guérin (BCG)-Unresponsive ...

WVE-007, an INHBE GalNAc-siRNA for obesity designed to drive fat loss while preserving muscle mass, achieved dose-dependent, mean reductions of Activin E of up to 85% in INLIGHT clinical trial, exceed ...

Results from an interim analysis in the Phase 2 STARBORN-1 trial of TARA-002 in pediatric LMs patients remain on track for 4Q ...

Heavy debts rattle investors already twitchy about runaway AI spending Oracle has taken a wallop as tech stocks and bonds ...

New subsidiary Alpha Modus Financial Services to drive multi-year national deployment of AI-powered financial kiosks in partnership with Uptiq CORNELIUS, N.C., Oct. 27, 2025 (GLOBE NEWSWIRE) -- Alpha ...

Net income from continuing operations of $5.9 million in Q3 2025 Gross margin increased 20.0% sequentially to 49.4% Balance sheet at September 30, 2025, strongest in the Company’s history with $81.5 ...